ORAI3 and breast carcinoma: Likewise, lower levels of ORAI3 would indeed be predicted in the breast cancer cells with high levels of NCS‐1 since ORAI3 levels are found to be lower in basal breast cancers (Azimi et al., 2019), which we have shown to have higher levels of NCS‐1.